COVID-19: Buying and Selling PPP Borrowers


Introduction

More than 4.5 million U.S. businesses have received loans through the Paycheck Protection Program (PPP), which was created under the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act). PPP loans have been a lifeline to many businesses, but also create complications for future M&A, investment, and financing transactions involving PPP borrowers. Those complications vary during the life cycle of a PPP loan and, unfortunately, some survive forgiveness or even repayment of such loan.

This alert discusses some of these key issues, primarily in the context of an M&A transaction, including:

Although these issues are new, the tools that M&A parties can use to deal with them are similar to the tools used to deal with many existing business, legal, regulatory, and tax issues.

Basic PPP Background

The CARES Act has been amended by two subsequent laws [1] and has been implemented through a dizzying array of regulations issued primarily by the U.S. Small Business Administration (the SBA). In simplest terms, as of the date of this alert, PPP loans:

For a more fulsome and detailed description of the PPP loan program, please see our firm’s summary term sheet.

PPP Loan Life Cycle and Related Issues

The first determination to be made in a transaction involving a PPP borrower is where the PPP borrower falls in the PPP loan life cycle, as the status of the PPP loan will dictate the issues to be addressed in the transaction. Highlights of the issues for each period of the life cycle are set forth below, and the issues are discussed in greater detail in the following sections of this alert.

Structural Considerations

There are several PPP-related issues that impact the parties’ decision whether to structure a transaction as an equity or asset deal, in addition to the traditional factors influencing such decision:

Purchase Price Considerations

Most transactions value the target on a “cash-free, debt-free” basis. For targets with outstanding PPP loans, both the “cash-free” and “debt-free” aspects of a transaction can present issues.

Due Diligence Concerns

PPP loan related risks do not end when the loan is repaid. As such, PPP-loan-specific diligence is advisable for any target that has ever obtained a PPP loan, even if such loan has been repaid or forgiven. All PPP borrowers have the legal burden to ensure that they obtained the PPP loan and used the PPP loan funds in accordance with all applicable laws. Such obligations survive the repayment or forgiveness of the PPP loan. SBA may review all PPP loans at any time, and statements made by a PPP borrower in its initial application or forgiveness application could be subject to claims under the False Claims Act. Penalties for inaccuracies or fraud may include immediate repayment of all loan amounts (if any amounts are still outstanding) and criminal and civil penalties.

M&A Transaction Document Provisions

However, from the buyer perspective, each of these potential covenants would have implications for the buyer in its post-closing operations and may hinder the operational success of the acquired business.

R&W Insurance/Indemnity

The market has not yet clearly settled on the extent to which representations and warranties insurance (RWI) will cover COVID-related representations generally, or in particular, PPP-related representations. If the parties intend to use RWI in the sale transaction, they will need to carefully review the RWI indication letters and policies for such exclusions. Buyers may need to negotiate with brokers to try to limit or exclude such exclusions with the provision of further diligence. However, if the RWI underwriter insists on excluding some or all PPP-related representations from coverage, a buyer may wish to consider requesting a special indemnity relating to the PPP-related risks noted above.

Conclusion

M&A activity during and following the COVID-19 pandemic, especially of targets that are PPP borrowers, will require enhanced diligence and may require additional tools to address new and unique concerns introduced by the pandemic and related government programs. Please also note that the rules, regulations, and statutes referenced in this alert continue to evolve and we expect new rules and FAQs to be issued, which may impact the positions taken in this alert. We are continuing to monitor the impact of COVID-19 and related legislation on M&A transactions and are working closely with clients to offer practical solutions to the unique challenges brought on by COVID-19. If you have questions regarding how to navigate this new environment, please do not hesitate to reach out to any of us at K&L Gates.


NOTES

  1. The Paycheck Protection Program and Health Care Enhancement Act, enacted on April 24, 2020 and the Paycheck Protection Program Flexibility Act of 2020 (the PPPFA), enacted on June 5, 2020.
  2. The CARES Act confusingly uses the term “covered period” for two different purposes and time periods, so we will refer to the “covered period” used in determining forgiveness as the “forgiveness covered period.”
  3. There does not appear to be a specific deadline by which a borrower must apply for forgiveness, but as noted below, a borrower who fails to apply for forgiveness within 10 months of the end of the forgiveness covered period must begin making repayments of the applicable PPP loans.
  4. If a lender determines to reject any portion of the requested forgiveness amount, the lender must also notify the borrower of such decision.
  5. Under the current rules, it appears that a borrower could thereafter still apply for forgiveness, but it would be required to start making and continue making payments.
  6. The ERC is a 50 percent credit against up to a maximum of $10,000 in qualified wages (including allocable health care benefits) per employee paid after March 13, 2020 and before January 1, 2021. Many significant eligibility determinations for this credit are made applying complex aggregation rules to treat the claimant and its affiliates as a single employer. Please see “COVID-19: CARES Act Employer Payroll Retention Tax Credit” for more details about this credit.
  7. There is a safe harbor exception for a PPP borrower who repaid its PPP loan prior to May 18, 2020. The ERC guidance treats such a borrower as if it never had a PPP loan for this purpose.
  8. Please see “COVID-19: Affiliation & Aggregation Considerations for the Paycheck Protection Program and the Employee Retention Credit” for more details about the loss of the ERC.
  9. The “HEROES Act” passed by the House would have corrected this issue by removing the PPP loan limitation to ERC claims in general, but faced opposition in the Senate.
  10. In rare circumstances, the parties may be looking to sign an acquisition agreement for a company that is considering a PPP loan or that has a pending PPP application. Note that a buyer will become an affiliate of the target upon signing a definitive agreement (but not most letters of intent) to acquire the equity of the target, which could create PPP size and eligibility issues because SBA regulations consider “agreements to merge (including agreements in principle) to have present effect.”

Copyright 2025 K & L Gates
National Law Review, Volume X, Number 174